Nvidia among investors in xAI’s $20 bln capital raise- Bloomberg
Tilray Inc. stock reached a new 52-week high, climbing to $1.85, marking a significant milestone for the $2.02 billion market cap company. The cannabis producer, with annual revenues of $821.31M and 4.1% growth, has shown impressive momentum with a 73.5% surge over the past six months. According to InvestingPro analysis, the stock appears slightly overvalued at current levels. The cannabis company has navigated market fluctuations and regulatory challenges, maintaining a healthy liquidity position with a current ratio of 2.46. This recent peak underscores its efforts to strengthen its market position, though trading at a notably high EV/EBITDA multiple of 50.7x. Investors are closely watching Tilray’s performance as the company continues to expand its footprint in the burgeoning cannabis industry. Discover 12 additional key insights about Tilray with InvestingPro’s exclusive analysis and comprehensive research report.
In other recent news, Tilray Brands Inc. has been in the spotlight following several key developments. Jefferies has raised its price target for Tilray from $1.50 to $2.00, maintaining a Buy rating, citing potential federal policy shifts regarding cannabis rescheduling in the United States. Additionally, Tilray’s stock experienced a decline after the company sought an extension to meet Nasdaq’s listing standards, with its share price trading below the required $1 minimum. In response, Tilray is considering options such as a reverse stock split to maintain its listing. Furthermore, Breckenridge Distillery, owned by Tilray, appointed Winebow as its distributor in California, expanding its market reach. This agreement will cover Breckenridge’s entire spirits line, leveraging Winebow’s facilities and relationships for distribution. Meanwhile, President Donald Trump’s recent video highlighting the benefits of hemp-derived CBD for seniors has led to increased interest in cannabis stocks, including Tilray. These developments underscore Tilray’s active engagement in both market expansion and regulatory compliance efforts.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.